MedPath

Exelon

Approved
Approval ID

29481887-34eb-460a-bd7f-b8755473065a

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 22, 2010

Manufacturers
FDA

Physicians Total Care, Inc.

DUNS: 194123980

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

rivastigmine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code54868-6070
Application NumberNDA022083
Product Classification
M
Marketing Category
C73594
G
Generic Name
rivastigmine
Product Specifications
Route of AdministrationTRANSDERMAL
Effective DateMarch 24, 2010
FDA Product Classification

INGREDIENTS (2)

ALPHA-TOCOPHEROLInactive
Code: H4N855PNZ1
Classification: IACT
RIVASTIGMINEActive
Quantity: 4.6 mg in 24 [USP'U]
Code: PKI06M3IW0
Classification: ACTIB

rivastigmine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code54868-5954
Application NumberNDA022083
Product Classification
M
Marketing Category
C73594
G
Generic Name
rivastigmine
Product Specifications
Route of AdministrationTRANSDERMAL
Effective DateMarch 24, 2010
FDA Product Classification

INGREDIENTS (2)

RIVASTIGMINEActive
Quantity: 9.5 mg in 24 [USP'U]
Code: PKI06M3IW0
Classification: ACTIB
ALPHA-TOCOPHEROLInactive
Code: H4N855PNZ1
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.